vs
Side-by-side financial comparison of Commercial Vehicle Group, Inc. (CVGI) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Commercial Vehicle Group, Inc. is the larger business by last-quarter revenue ($154.8M vs $103.7M, roughly 1.5× Twist Bioscience Corp). On growth, Twist Bioscience Corp posted the faster year-over-year revenue change (16.9% vs -5.2%). Commercial Vehicle Group, Inc. produced more free cash flow last quarter ($8.7M vs $-34.8M).
WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
CVGI vs TWST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $154.8M | $103.7M |
| Net Profit | — | $-30.5M |
| Gross Margin | 9.7% | 52.0% |
| Operating Margin | -1.2% | -31.7% |
| Net Margin | — | -29.4% |
| Revenue YoY | -5.2% | 16.9% |
| Net Profit YoY | — | 3.4% |
| EPS (diluted) | — | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $154.8M | $103.7M | ||
| Q3 25 | $152.5M | — | ||
| Q2 25 | $172.0M | — | ||
| Q1 25 | $169.8M | — | ||
| Q4 24 | $163.3M | — | ||
| Q3 24 | $171.8M | — | ||
| Q2 24 | $193.7M | — | ||
| Q1 24 | $194.6M | — |
| Q4 25 | — | $-30.5M | ||
| Q3 25 | $-7.1M | — | ||
| Q2 25 | $-4.8M | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.5M | — | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $2.9M | — |
| Q4 25 | 9.7% | 52.0% | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 9.6% | — | ||
| Q2 24 | 10.6% | — | ||
| Q1 24 | 11.9% | — |
| Q4 25 | -1.2% | -31.7% | ||
| Q3 25 | -0.7% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | -3.2% | — | ||
| Q3 24 | -0.6% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | — | -29.4% | ||
| Q3 25 | -4.6% | — | ||
| Q2 25 | -2.8% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | -0.8% | — | ||
| Q1 24 | 1.5% | — |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.05 | — | ||
| Q1 24 | $0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $197.9M |
| Total DebtLower is stronger | $104.9M | — |
| Stockholders' EquityBook value | $133.4M | $456.1M |
| Total Assets | $391.7M | $638.1M |
| Debt / EquityLower = less leverage | 0.79× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $197.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $104.9M | — | ||
| Q3 25 | $108.2M | — | ||
| Q2 25 | $118.2M | — | ||
| Q1 25 | $117.4M | — | ||
| Q4 24 | $135.5M | — | ||
| Q3 24 | $128.8M | — | ||
| Q2 24 | $142.0M | — | ||
| Q1 24 | $155.7M | — |
| Q4 25 | $133.4M | $456.1M | ||
| Q3 25 | $136.5M | — | ||
| Q2 25 | $142.6M | — | ||
| Q1 25 | $136.7M | — | ||
| Q4 24 | $135.6M | — | ||
| Q3 24 | $179.3M | — | ||
| Q2 24 | $169.6M | — | ||
| Q1 24 | $175.5M | — |
| Q4 25 | $391.7M | $638.1M | ||
| Q3 25 | $400.3M | — | ||
| Q2 25 | $429.8M | — | ||
| Q1 25 | $419.8M | — | ||
| Q4 24 | $424.6M | — | ||
| Q3 24 | $495.3M | — | ||
| Q2 24 | $503.2M | — | ||
| Q1 24 | $509.2M | — |
| Q4 25 | 0.79× | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 1.00× | — | ||
| Q3 24 | 0.72× | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 0.89× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $-24.8M |
| Free Cash FlowOCF − Capex | $8.7M | $-34.8M |
| FCF MarginFCF / Revenue | 5.6% | -33.5% |
| Capex IntensityCapex / Revenue | 2.3% | 9.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | $-24.8M | ||
| Q3 25 | $-1.7M | — | ||
| Q2 25 | $18.9M | — | ||
| Q1 25 | $15.2M | — | ||
| Q4 24 | $-26.6M | — | ||
| Q3 24 | $-17.1M | — | ||
| Q2 24 | $12.6M | — | ||
| Q1 24 | $-2.4M | — |
| Q4 25 | $8.7M | $-34.8M | ||
| Q3 25 | $-3.5M | — | ||
| Q2 25 | $17.4M | — | ||
| Q1 25 | $11.4M | — | ||
| Q4 24 | $-30.6M | — | ||
| Q3 24 | $-20.3M | — | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $-7.4M | — |
| Q4 25 | 5.6% | -33.5% | ||
| Q3 25 | -2.3% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 6.7% | — | ||
| Q4 24 | -18.7% | — | ||
| Q3 24 | -11.8% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | -3.8% | — |
| Q4 25 | 2.3% | 9.6% | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 2.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.79× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.80× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
